<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Shrestha Palikhe N</submitter><funding>Western University</funding><funding>Canadian Allergy, Asthma and Immunology Foundation</funding><funding>Canadian Institutes of Health Research</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>CRTh2 is G protein coupled receptor for prostaglandin D2 (PGD)&lt;sub>2&lt;/sub> expressed by immune cells that drive type 2 inflammation such as CD4&lt;sup>+&lt;/sup> T cells (Th2), eosinophils and group 2 innate lymphoid cells (ILC2) as well as structural cells including smooth muscle and epithelium. CRTh2-expressing cells are increased in the blood and airways of asthmatics and severe asthma is characterized by increased activity of the PGD&lt;sub>2&lt;/sub>-CRTh2 pathway. The &lt;i>CRTh2&lt;/i> single nucleotide polymorphism (SNP) rs533116 G > A is associated with development of asthma and increased Th2 cell differentiation.&lt;h4>Objective&lt;/h4>To examine whether CRTh2 rs533116G > A associates with asthma severity. Since severe asthma is more common in females than males, we performed a sex-stratified analysis.&lt;h4>Methods&lt;/h4>Clinical data from asthmatics (&lt;i>n&lt;/i> = 170) were obtained from clinic visits and chart review. Asthma severity was assessed according to ERS/ATS guidelines. Peripheral blood cells were characterized by flow cytometry and qRT-PCR. Genotyping was performed by TaqMan assay.&lt;h4>Results&lt;/h4>Older females (≥45 years) homozygous for minor A allele of rs533116 were more likely to have severe asthma, lower FEV&lt;sub>1&lt;/sub>, a higher prescribed dose of inhaled corticosteroid and more type 2 inflammation than females carrying GA or GG genotypes. Comparing females and males with the AA genotype also revealed that women had more type 2 inflammation.&lt;h4>Conclusions and significance&lt;/h4>The polymorphism CRTh2 rs533116 G > A associates with severe asthma and type 2 inflammation in older females. This study reveals a gene-sex-aging interaction influencing the effect of CRTh2 on asthma severity.</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>970495</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9606418</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The CRTh2 polymorphism rs533116 G > A associates with asthma severity in older females.</pubmed_title><pmcid>PMC9606418</pmcid><pubmed_authors>Cameron L</pubmed_authors><pubmed_authors>Vliagoftis H</pubmed_authors><pubmed_authors>Kim RB</pubmed_authors><pubmed_authors>Shrestha Palikhe N</pubmed_authors><pubmed_authors>Mackenzie CA</pubmed_authors><pubmed_authors>Licskai C</pubmed_authors></additional><is_claimable>false</is_claimable><name>The CRTh2 polymorphism rs533116 G > A associates with asthma severity in older females.</name><description>&lt;h4>Background&lt;/h4>CRTh2 is G protein coupled receptor for prostaglandin D2 (PGD)&lt;sub>2&lt;/sub> expressed by immune cells that drive type 2 inflammation such as CD4&lt;sup>+&lt;/sup> T cells (Th2), eosinophils and group 2 innate lymphoid cells (ILC2) as well as structural cells including smooth muscle and epithelium. CRTh2-expressing cells are increased in the blood and airways of asthmatics and severe asthma is characterized by increased activity of the PGD&lt;sub>2&lt;/sub>-CRTh2 pathway. The &lt;i>CRTh2&lt;/i> single nucleotide polymorphism (SNP) rs533116 G > A is associated with development of asthma and increased Th2 cell differentiation.&lt;h4>Objective&lt;/h4>To examine whether CRTh2 rs533116G > A associates with asthma severity. Since severe asthma is more common in females than males, we performed a sex-stratified analysis.&lt;h4>Methods&lt;/h4>Clinical data from asthmatics (&lt;i>n&lt;/i> = 170) were obtained from clinic visits and chart review. Asthma severity was assessed according to ERS/ATS guidelines. Peripheral blood cells were characterized by flow cytometry and qRT-PCR. Genotyping was performed by TaqMan assay.&lt;h4>Results&lt;/h4>Older females (≥45 years) homozygous for minor A allele of rs533116 were more likely to have severe asthma, lower FEV&lt;sub>1&lt;/sub>, a higher prescribed dose of inhaled corticosteroid and more type 2 inflammation than females carrying GA or GG genotypes. Comparing females and males with the AA genotype also revealed that women had more type 2 inflammation.&lt;h4>Conclusions and significance&lt;/h4>The polymorphism CRTh2 rs533116 G > A associates with severe asthma and type 2 inflammation in older females. This study reveals a gene-sex-aging interaction influencing the effect of CRTh2 on asthma severity.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-05-03T10:32:48.639Z</modification><creation>2025-05-29T16:10:59.711Z</creation></dates><accession>S-EPMC9606418</accession><cross_references><pubmed>36314028</pubmed><doi>10.3389/fmed.2022.970495</doi></cross_references></HashMap>